Globally Trusted Brands
Product
Categories
Tigecycline Injection
Available Strength: 50 mg
- Available for Exports with all Documents
- Dossier Available as per ACTD format
- International Accreditations and Approvals
- Competitive Pricing
- Regional Business Development Support
- Best Quality and Packaging
- Minimum Order Quantity Support
- Quick Delivery and Lead Time
Product Details
Revetus Healthcare is India based exporter of Antibiotics Tigecycline Injection. Tigecycline is the first drug in the glycylcycline class of antibiotics. Although it is structurally related to minocycline, alterations to the molecule resulted in its expanded spectrum of activity and decreased susceptibility to the development of resistance when compared with other tetracycline antibiotics. It is used to treat bacterial infections in many different parts of the body (eg, infections on the skin, stomach, or lungs).
All products are manufactured at GMP approved facilities with modern infrastructure and analytical capabilities, ensuring better results and safety for patients. Our products are well accepted globally. As a reputed and fast growing independent pharmaceutical company, we offer flexible terms of trade with individual attention to each business associates. We solve the challenges of working with an extended support so as to facilitate a productive & profitable long term business partnerships.
Our business activities include:
- Exports of wide range of branded and generic tablets, capsules, injections, oral liquids, topical products, sachets, powders, sterile dosage forms, premix for fill-finish projects and other medical products
- Contract Manufacturing / Third Party Manufacturing
- New Product Development / Formulation Developments for Pharmaceuticals as per regional guidelines
- Dossier Development with stability studies, validations, BABE and other requirements
For more information, write to us at exports@revetus.com
All International brands and products are regulated and comply as per country specific guidelines. For product specific detailed contents, ingredients, uses, indications, label claims, mechanism of action, dosage, how to use, side effects and drug interactions, please refer to Patient Information Leaflet (PIL) / Pack Insert (PI), also available in regional languages with product. To report any adverse drug reaction, side effects or any drug interaction, write to us at pv@revetus.com, pharmacovigilance department, mentioning batch number and manufacturing date.